Mandate

Vinge has advised Tobii AB (publ) in connection with an issue of MSEK 300 secured bonds

February 27, 2019 Banking and Finance

Vinge has advised Tobii AB (publ) in connection with the company’s issue of SEK 300,000,000 secured bonds, with a tenor of 3 years, under a SEK 600,000,000 framework.

The bonds mature in February 2022. Carnegie Investment Bank AB (publ) acted as arranger. The proceeds from the bond issue will be used for refinancing existing acquisition financings (including loan facilities) and for the financing of future acquisitions, as well as for general corporate purposes. 

The interest rate has been set to three months STIBOR plus 575 basis points. The bonds are secured through pledges over shares in existing and future material subsidiaries and through certain intra-group loans. 

Vinge’s team consisted primarily of Louise Brorsson Salomon, Josefine Larsson, Pauline Lagerstrand and Rikard Lindahl.

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026